Icon Cancer Centre

What Icon Cancer Centre does

Icon Cancer Centre (legal entity: Integrated Clinical Oncology Network Pty Ltd) is Australia's largest private day-only cancer care network and the Australian operating arm of the diversified healthcare conglomerate Icon Group. The company traces its clinical lineage to Haematology & Oncology Clinics of Australasia (HOCA) and is today headquartered in South Brisbane, Queensland. It operates cancer treatment centres across every Australian state and territory — including flagship sites in South Brisbane, Chermside (a 26-chair day oncology hospital), Hollywood in Western Australia, Melbourne, Sydney, Adelaide, Perth, Hobart, and Canberra — staffed by a large multidisciplinary team of radiation oncologists, medical oncologists, haematologists, specialist nurses, cancer care coordinators, and administrative staff.

Its offering spans the full breadth of modern oncology care: radiotherapy (including stereotactic radiotherapy, HyperArc, Gamma Knife, brachytherapy, Deep Inspiration Breath Hold, external beam radiotherapy, intensity-modulated and volumetric-modulated arc therapy, image-guided and surface-guided radiotherapy, and the TrueBeam and RapidArc platforms), chemotherapy and systemic anti-cancer therapy, immunotherapy, hormone therapy, targeted therapies, theranostics (notably Lutetium-177 PSMA therapy for prostate cancer), haematology for malignant and non-malignant blood disorders, bone marrow collection, and clinical apheresis. PET/CT and dedicated molecular imaging (including FDG and PSMA tracers, SPECT/CT, and a wide range of nuclear medicine scans) underpin diagnosis, staging, and treatment monitoring. Clinical trial access, scalp cooling systems to mitigate chemotherapy-induced hair loss, and a multidisciplinary supportive care program (including specialist prostate, melanoma, and bowel cancer nurses, palliative care, and the Icon Cancer Foundation) round out the service portfolio.

The business model is a healthcare-provider model delivering outpatient, day-hospital cancer treatment. Revenue is generated per treatment episode, predominantly reimbursed via private health insurance (Icon holds no-gap arrangements with most Australian private health funds for admitted MBS services) and self-funded out-of-pocket payments, with consultation costs and out-of-pocket amounts varying by individual treatment plan and policy. Patients are largely referred in by GPs and specialists through dedicated referral pathways and the Icon Doctor App; commercial discipline is reflected in operational metrics of 4 days to initial consultation, 5 days to radiotherapy start, and a 97/100 national patient experience score. Icon Cancer Centre sits within the wider Icon Group ecosystem, alongside pharmacy (Slade, Epic, Pharmaxo), health screening, and international cancer centres in New Zealand, Singapore, Malaysia, Indonesia, and the United Kingdom.

Name

Icon Cancer Centre

Legal name

Integrated Clinical Oncology Network Pty Ltd

Website

https://iconcancercentre.com.au

Company type

Private

Founded year

1988

Operating status

Operating

Headcount range

101–250 employees

Short description

Icon Cancer Centre is a private Australian day-only cancer care provider operating a national network of centres across all Australian states and territories, part of Icon Group. It delivers radiotherapy, chemotherapy, immunotherapy, targeted therapies, theranostics, and haematology to privately insured and self-funded cancer patients.

Ownership category

akta.pro rank

Product category

Oncology Services

NAICS

Offices of Physicians (62111), Offices of Physicians (6211)

SIC

Services-Hospitals (8060), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Radiation Oncology (HLAKAFAC), Nuclear Medicine Clinical Services & Therapy Centers (HLAIAGAI)

Keywords

• Cancer treatment services
• Private oncology care
• Radiotherapy services
• Chemotherapy treatment
• Cancer care network

Headquarters

HQ city

Brisbane

HQ country

Australia

HQ region

Oceania

Offices9 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Infrastructure, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Cancer Treatment Services: Icon Cancer Centre generates revenue through providing comprehensive cancer treatment services including chemotherapy, radiotherapy, immunotherapy, targeted therapies, hormone therapy, theranostics, haematology treatments, and supportive care. Services are delivered as outpatient day hospital treatments.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Icon Cancer Centre operates Australia's leading private day-only cancer care network, delivering comprehensive oncology treatments including radiotherapy, chemotherapy (SACT), immunotherapy, hormone therapy, targeted therapies, theranostics, and haematology services. Treatment is provided across a national network of cancer centres in all Australian states and territories, with rapid access pathways (4 days to initial consultation, 5 days to start of radiotherapy).

Product overview

Icon Cancer Centre operates Australia’s leading network of private day-only cancer care services, offering a comprehensive portfolio of treatment modalities. The core offering centres on radiotherapy (including advanced techniques like Stereotactic Radiotherapy, HyperArc, Gamma Knife, TrueBeam, and PET/CT molecular imaging) and chemotherapy (SACT services). These are complemented by immunotherapy, hormone therapy, targeted therapies, and theranostics (Lutetium-177 PSMA therapy). The network also provides haematology services, bone marrow collection, and apheresis. Support services include specialist nurses, care coordinators, and wellness programs. Treatment is delivered across multiple Australian centres with rapid access (4 days to initial consultation, 5 days to radiotherapy start).

Differentiator

Problem solved

Functional benefit

Brands

• Icon Doctor App: Mobile application for doctor referrals and patient management
• Icon Cancer Foundation
• InteleConnect

Products and services

• Chemotherapy (SACT - Systemic Anti-Cancer Therapy) Use of anti-cancer drugs to destroy cancer cells, delivered as outpatient treatment at Icon day hospitals. Includes oral, intravenous, organ-directed, and topical chemotherapy delivery methods, typically administered in multiple cycles.
• Radiotherapy Treatment Services Advanced radiotherapy treatment modalities offered across Icon's national network, including stereotactic radiotherapy, HyperArc, Gamma Knife, brachytherapy, DIBH, external beam radiotherapy, IGRT, IMRT, VMAT, adaptive radiotherapy, TrueBeam, and RapidArc Dynamic techniques.
• PET/CT Imaging Positron Emission Tomography–Computed Tomography combining functional PET imaging with detailed CT anatomy for cancer diagnosis, staging, and monitoring. Uses FDG and PSMA tracers for oncology, brain, and cardiac applications.
• Molecular Imaging Specialised imaging using radioactive tracers to capture cellular-level body function. Includes bone scans, cerebral SPECT/CT, DMSA renal scans, gallium scans, HIDA scans, MAG3 renal scans, MUGA scans, parathyroid scans, sentinel node scans, sestamibi renal scans, and thyroid uptake scans.
• Immunotherapy Cancer treatment that uses the body's immune system to fight cancer cells.
• Hormone Therapy Treatment that uses hormones to slow or stop the growth of certain cancers.
• Targeted Therapies Cancer treatments that target specific genes, proteins, or the tissue environment that contributes to cancer growth and survival.
• Theranostics Combines diagnostic imaging with targeted radiopharmaceutical therapies, enabling personalised treatment based on individual patient imaging. Includes Lutetium-177 PSMA therapy for prostate cancer.
• Haematology Services Treatment for malignant and non-malignant blood disorders including leukaemia, lymphoma, myeloma, and blood disorders. Includes stem cell transplantation and clinical apheresis.
• Bone Marrow Collection Procedure for collecting bone marrow for transplantation or diagnostic purposes.
• Apheresis Blood component separation procedure used in the treatment of various conditions.
• Clinical Trials Access to clinical trials across a wide range of tumour types and phases for eligible patients.
• Cancer Support Services Comprehensive support including cancer care coordinators, specialist prostate/melanoma/bowel cancer nurses, cancer wellness programs, palliative care, and family/carer support.
• Icon Cancer Centre Chermside Medical oncology and haematology centre in Brisbane offering chemotherapy, targeted therapies, immunotherapy, and treatment for blood disorders. Features a 26-chair day oncology hospital with scalp cooling.
• Icon Cancer Centre Hollywood Western Australia's first integrated theranostics centre combining molecular imaging (PET/CT, SPECT/CT) with targeted radiopharmaceutical therapies and access to global clinical trials.

Quantifiable outcome

• 4 days to initial consultation
• +2 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

One partnership is on record.

• Icon GroupcoreStrategic or Co-development PartnerIcon Cancer Centre is part of the Icon Group network, which operates cancer treatment facilities across Australia, New Zealand, Singapore, Malaysia, Indonesia, and the United Kingdom. Icon Cancer Centre is the Australian operations of this integrated cancer care network.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• GenesisCare: Australia's largest private cancer care provider, offering radiotherapy, medical oncology, and theranostics across a national network. GenesisCare is Icon's closest direct competitor in private Australian oncology with overlapping service lines and referral-based GTM.
• Cancer Care Associates: Australian private oncology operator providing medical oncology, radiotherapy, and haematology services across multiple sites. Comparable to Icon as a multi-modality private cancer provider serving similar patient cohorts in Australia.
• Icon Oncology (Malaysia): Sister entity under Icon Group providing oncology services in Malaysia. Directly comparable as the same parent company operating the same cancer care model in a different geography, validating the platform's replicability.
• Bowen Icon Cancer Centre (New Zealand): Icon Group's New Zealand cancer care entity operating private radiotherapy and chemotherapy services. Directly comparable as a sister subsidiary running the same clinical model in a trans-Tasman market with similar patient pathways.

Broad incumbents

• Ramsay Health Care: Largest private hospital operator in Australia, with oncology and day oncology services embedded in its hospital network. Comparable as a private healthcare delivery platform, though cancer is one of many service lines rather than a specialised focus.
• Healthscope: Major Australian private hospital operator (owned by Brookfield) providing a broad range of services including oncology and day infusion. Overlaps with Icon on private cancer care delivery but lacks Icon's standalone specialty cancer focus.
• Healius Limited: Australian healthcare company operating diagnostic imaging, pathology, and day hospitals including oncology services. Comparable as a diversified Australian private healthcare provider with imaging overlap (PET/CT) where Icon has Icon Health Screening.

Regional players

• Peter MacCallum Cancer Centre: Australia's largest public specialty cancer hospital, headquartered in Melbourne. Comparable as a leading oncology provider with advanced radiotherapy and theranostics capabilities, though it operates as a public institution rather than a private competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/iconcancerctre
• YouTubeyoutube.com/@iconcancercentre
• Facebookfacebook.com/iconcancercentre
• LinkedInlinkedin.com/showcase/3338375
• Instagraminstagram.com/iconcancercentre

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Icon Cancer Centre